Svenja Tatjana Barckhausen: From Plasma Dependence to Self-Sufficiency in Africa
Svenja Tatjana Barckhausen, CEO and Founder of Blood Plasma Strategy Experts, shared a post on LinkedIn:
“Africa is still undersupplied with erythrocytes and plasma derived medicinal products (pdmP).
Improvement is possible and the potential is huge to become self-sufficient and strengthen access to care through own efforts.
African nations can hardly afford pdmP’s made from expensive US plasma that accounts for more than 70 percent of global plasma collection.
As a result, too many patients remain untreated.
Countries can rise from dependence to independence by collecting enough plasma for fractionation.
By strengthening local collection, countries can move from dependence on costly imports toward true independence and sustainable access to care.
Encouragingly, during the AfSBT Congress in Namibia this March, where I had the privilege to participate, I sensed a shift: awareness is growing that local collection of blood and plasma for fractionation is not just important — it’s essential for the continent’s future healthcare resilience.
Several models were discussed by different speaker and high level attendees such like the minister of health of Namibia, representatives from European blood banks and governments as well as the WHO had representative attending.
One immediate step is to make Recovered Plasma from whole‑blood donations available for fractionation.
Beyond that, introducing plasmapheresis and establishing sustainable plasma collection will be essential to achieving plasma product independence across the continent.
This approach benefits everyone: blood banks can reinvest proceeds from plasma utilization to strengthen their national transfusion services.
Introducing plasmapheresis and sustainable plasma collection systems will not only improve access to PDMPs but also drive Africa toward self-sufficiency.
Importantly, each country should be empowered to choose its own path — whether developing national fractionation facilities or creating regional collaborations that fit their healthcare and political realities.
Several nations have already started demonstrating that this goal is achievable.
Egypt has already shown that establishing plasmapheresis programs is possible in Africa.
Namibia’s initiative to use its Recovered Plasma is another strong example – a small but powerful step toward greater access to care across the continent.
The vision is clear: Africa can produce its own plasma for fractionation to build resilient, independent, and sustainable access to care.”

Stay updated with Hemostasis Today.
-
Sep 5, 2026, 16:28Jon Douglas: Imperial College London Review Maps Key Pathways in Autoimmune Thrombosis
-
Sep 5, 2026, 16:21Kelly Anderson: Bilateral Foot Pain and Purple Toes – Spotting Vascular Complications in Polycythemia Vera
-
Sep 5, 2026, 16:16Hazem Abosheaishaa: Beta-Blocker Selection Matters – Multi-Institutional Cohort Insights on PVT and Survival in Cirrhosis
-
Sep 5, 2026, 16:08Indre Ceponiene: Major Gaps in Secondary Cardiovascular Prevention Across Europe
-
Sep 5, 2026, 16:03W. Alberto Sifuentes Giraldo: Why Obstetric Cases Are Missed Under 2023 ACR/EULAR APS Criteria
-
Sep 5, 2026, 15:58Srikanth Nalla: A Case of Saddle Pulmonary Embolism
-
Sep 5, 2026, 15:55COPD-specific Pulmonary Embolism Diagnostic Strategy – Thrombosis and Haemostasis
-
Sep 5, 2026, 15:41Sam Tsimikas on Lp(a) HORIZON Topline Results – What Missed Endpoints Mean for Cardiovascular Risk
-
Sep 5, 2026, 15:32Stefano Garzon: SELUTION DeNovo HBR – Weren’t HBR Patients Supposed to Bleed More with DES?